可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Wallenfeldt K,Bokemark L,Wikstrand J,et al.Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men[J].Stroke,2004,35(10):2248-2252.
[2]Schmidt C,Wikstrand J.High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long-term follow-up in the AIR study[J]. Atherosclerosis,2009,205(1):284-289.
[3]Natarajan P,Ray KK,Cannon CP.High-density lipoprotein and coronary heart disease: current and future therapies[J].J Am Coll Cardiol,2010, 55(13):1283-1299.
[4]Enkhmaa B,Anuurad E,Zhang Z,et al.Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans[J].Am J Cardio,2010,106(9):1264-1269.
[5]He Y,Jiang B,Wang J,et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population[J].J Am Coll Cardiol,2006,47(8):1588-1594.
[6]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
[7]Walldius G,Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence[J].J Intern Med,2006,259(5):493-519.
[8]Takiuchi S,Kamide K,Miwa Y,et al.Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension[J]. J Hum Hyperten,2004,18(1):17-23.